John Park

Projects

Projects per year 2018 2020 2027

• 1 Not started
• 5 Finished
• 19 Active

Projects per year

Search results

• Finished

  ZN-c5-002: A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with EstrogenReceptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.

  Sabanathan, D., Park, J. & Chapman, N.

  15/10/20 → 23/07/21

  Project: Research

• SHR-A1811-1-101: A Phase 1 Multi-Country, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-A1811 in HER2 Expressing or Mutated Advanced Malignant Solid Tumor Subjects

  Park, J. & Chapman, N.

  28/09/20 → 31/12/22

  Project: Research

• CONTESSA: A Multicenter, Phase 2 Study of Tesetaxel plus Three Different PD-(L)1 Inhibitors in Patients with Triple-Negative, Locally Advanced or Metastatic Breast Cancer and Tesetaxel Monotherapy in Elderly Patients with HER2 Negative, Locally Advanced or Metastatic Breast Cancer

  Sabanathan, D., Park, J., Gilchrist, J., Rai, M. & Chapman, N.

  1/05/20 → 18/06/21

  Project: Research

• Oncogenic Signaling in Uveal Melanoma

  Park, J. & Rizos, H.

  4/09/19 → 3/09/20

  Project: Research

• MISC_Sydney Vital: To investigate circulating tumour DNA as a biomarker of resistance in metastatic uveal melanoma treated with PKC inhibitor (LXS196)

  Rizos, H. & Park, J.

  1/07/18 → 30/06/19

  Project: Other